Introduction
Inorganic arsenite, arsenic trioxide, induces complete remission in a high proportion of patients with refractory acute promyelocytic leukemia (APL) (1--3) and has been approved for treatment of relapsed or refractory APL by the US Food and Drug Administration. The fact that arsenic trioxide is effective in patients refractory to conventional chemotherapy suggests that arsenic kills cancer cells via mechanisms different from those of conventional anticancer drugs. It is generally accepted that arsenic trioxide cures APL by induction of apoptosis (4, 5) . Recently, it was shown that inorganic arsenite could also induce apoptosis in a variety of solid tumor cells (6--9) . However, it is not yet known how these cancer cells respond to arsenite and what determines their susceptibility.
The mechanism by which arsenic triggers apoptosis remains controversial. There is evidence that it down-regulates Bcl-2 protein and activates caspase-3-like caspase activity (4) . Some reports have shown that arsenic-induced apoptosis is caused by a direct effect on the mitochondrial permeability transition pore, resulting in loss of the mitochondrial transmembrane potential (5) . Other studies have demonstrated that arsenic compounds can disrupt mitosis and therefore induce apoptosis in a variety of cell systems (7,10--13) . The disruption of mitosis was shown to be due to interference with tubulin polymerization and disruption of mitotic spindles (7, 10, 14) .
Mitotic abnormalities often arise directly from defects of centrosomes and/or mitotic spindles, which then induce prolonged mitotic arrest or delayed mitotic exit and trigger induction of apoptosis (15, 16) . Recent reports have demonstrated that entry into mitosis in the presence of damaged DNA leads to inactivation of centrosomes, formation of aberrant spindles and blockage of chromosome segregation, which consequently delays mitosis progression and induces mitotic abnormalities (17, 18) . In addition, chemical or pharmacological inhibition of the DNA damage checkpoint at the G 2 stage induces premature entry into mitosis and subsequent initiation of apoptosis (19) . However, the mechanism linking perturbation of the cell cycle to initiation of apoptosis is not fully understood.
In our previous study, we demonstrated that arsenite induces apoptosis in HeLa cells by arresting cells at the mitotic stage (11) . In the present study, we demonstrated that arsenite induced more prominent mitotic arrest in CGL-2 cells than in other cell lines tested. Arsenite-arrested mitotic CGL-2 cells were also more susceptible to induction of apoptosis. CGL-2 cells, a fusion hybrid of the HeLa adenocarcinoma cell line and normal human fibroblasts, originally established for the analysis of transformation and tumorigenicity, are chromosomally stable and behave as transformed cells in culture, but their tumorigenic potential is suppressed (20) . This high susceptibility of CGL-2 cells to arseniteinduced mitotic arrest and apoptosis provides an ideal model for studying the processes coupling arsenite induction of mitotic abnormalities to the onset of apoptosis. Elucidation of these processes might reveal sites of potential intervention for the use of arsenic in cancer chemotherapy.
Materials and methods

Cell culture
The CGL-2 cell line (21) , derived from a hybrid (ESH5) of the HeLa variant, D98/AH2, and a normal human fibroblast strain, GM77, was kindly provided by Dr E.J.Stanbridge (University of California-Irvine). HeLa S3 cells were obtained from American Type Culture Collection (Manassas, VA). These cells were routinely maintained in Dulbecco's modified Eagle medium (GIBCO, Grand Island, NY) supplemented with 10% fetal bovine serum (Hyclone Laboratories, Logan, UT), 0.37% sodium bicarbonate (GIBCO), 100 U/ml of penicillin (GIBCO), and 100 mg/ml of streptomycin (GIBCO) at 37 C in an humidified incubator in air and 10% CO 2 . The cells were routinely passaged twice per week.
Drug treatment
Logarithmically growing CGL-2 cells were treated for 24 h at 37 C with 1--10 mM arsenite, 0.01--0.1 mM nocodazole or 0.01--0.1 mM taxol, then harvested and analyzed. In most experiments, all the cells were used, but, in experiments in which floating and adherent cells were analyzed separately, the culture dishes were gently shaken and cells floating in the culture medium were collected by centrifugation at 800 g for 5 min. The remaining attached cells were collected by trypsinization.
X-irradiation
Logarithmically growing CGL-2 cells were irradiated at room temperature in complete medium using a Torrex 150D X-ray machine (EG&G, Astrophysics Research, Long Beach, CA) operating at 134 kV and 4 mA with a 1.2 mm beryllium filter at a dose rate of 6 Gy/min. A calibrated in-field ionizing monitor was used during each irradiation to ensure the accuracy of the delivered dose.
Cytotoxicity assay
Logarithmically growing CGL-2 cells were treated for 24 h at 37 C with various concentrations of arsenite. The relative survival rate was then determined using a colony-forming assay as described previously (22) . In brief, after arsenite treatment, the cells were collected, counted, serially diluted and seeded in triplicate at a density of 200--2000 cells/dish in 60-mm Petri dishes and incubated for 10 days. Colonies were visualized and counted after fixing with 70% ethanol and staining with 3% Giemsa solution (Merck, Darmstadt, Germany). The plating efficiency of each treatment was calculated by dividing the number of colonies on each plate by the number of cells seeded. The relative survival rate was determined by normalization of the plating efficiency for each treatment with that for the untreated control.
Analysis of cell-cycle progression and mitotic index Cell-cycle progression was monitored using DNA flow cytometry. In brief, the cells were trypsinized, washed once with phosphate-buffered saline (PBS), fixed with ice-cold 70% ethanol for 16 h, and stained with 4 mg/ml of propidium iodide in PBS containing 1% Triton X-100 and 0.1 mg/ml of RNase A. The DNA content of individual cells was analyzed using a fluorescence activated cell sorter (FACSTAR, Becton Dickinson Immunocytometry Systems), and the cell-cycle distribution of the cells determined using a computer program provided by Becton Dickinson Immunocytometry System as described previously (22) . The cell suspension was then observed under a fluorescence microscope (Axioskop 2, Zeiss, Germany) to determine the mitotic index; at least 500 cells were scored in each sample and three independent measurements were performed to determine the mitotic index.
Synchronization of CGL-2 cells
The synchronization of G 1 -enriched cells was achieved by the protocol of double-thymidine block (23) . Logarithmically growing CGL-2 cells at 50% confluence were treated with 2 mM thymidine for 12 h, switched to thymidinefree medium for 12 h, then again treated with 2 mM thymidine for 12 h. At this point, the majority of the cells were at the G 1 /S boundary. They were then allowed to progress forward by switching them to thymidine-free medium, and the cell-cycle progression was monitored at 2--4 h intervals using a DNA flow cytometer as described above.
Immunofluorescence staining of g-H2AX CGL-2 cells seeded on glass coverslips were incubated for 24 h at 37 C with or without 2 mM arsenite, washed twice with PBS, and then fixed in situ with 90% methanol at À20 C for 10 min. The coverslips were again washed twice with PBS and incubated for 1 h at 37 C with anti-g-H2AX antibody (Upstate USA, Charlottesville, VA), then non-bound antibody was removed by extensive washing with PBS containing 0.2% Tween (PBST). The coverslips were then incubated for 30 min at 37 C in the dark with fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Organon Teknika-Cappel, Belgium), and nuclei were simultaneously counterstained with 0.1 mg/ml of 4,6-diamino-2-phenyl-indole (DAPI) (Sigma, St Louis, MO). After thorough rinsing with PBST, the coverslips were mounted with a 90% glycerol solution containing 1 mg/ml of phenylenediamine (pH 8.0, Merck, Gibbstown, NJ) and the g-H2AX foci in cells examined under a fluorescence microscope (Axioskop 2, Zeiss, Germany).
Immunoblots
Levels of cyclin B, Pds1, phospho-histone H3, phospho-Cdc25C (serine 216), total ataxia-telangiectasia, mutated (ATM) and phospho-ATM (serine 1981) proteins in total cell extracts were examined by western blotting as described previously (22) . Briefly, CGL-2 cells after treatment were washed twice with ice-cold PBS, scraped off, collected in a 1.5 ml vial, and boiled in SDS--PAGE sample buffer (24) . Samples of cellular proteins (20--50 mg) were resolved by 6 or 12% SDS--PAGE, transferred onto polyvinylidene difluoride membranes (Amersham Biosciences, Piscataway, NJ), and probed with the appropriate antibodies. b-Actin was used as a loading control. The results shown are representative of at least two independent experiments. Rabbit polyclonal anti-cyclin B1 and goat polyclonal anti-ATM and anti-b-actin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), mouse monoclonal anti-Pds1 antibody from NeoMarkers (Fremont, CA), rabbit polyclonal anti-phospho-H2AX (serine 139) antibodies from Upstate Biotechnology (Waltham, MA), mouse monoclonal anti-phospho-histone H3 (serine 10) antibody and rabbit polyclonal anti-phospho-Cdc25C (serine 216) antibodies from Cell Signaling Technology (Beverly, MA), and rabbit polyclonal antiphospho-ATM (serine 1981) antibodies from Rockland (Gibertsville, PA). Protein concentrations were determined by Bradford analysis (25) .
Apoptosis assay
The number of apoptotic cells was determined using an Annexin V--FITC apoptosis detection kit (Oncogene, Boston, MA) as described previously (11) . The cells were trypsinized, washed once with PBS, and resuspended in 100 ml of binding buffer containing 5 ml of 200 mg/ml FITC-conjugated Annexin V and 5 ml of 30 mg/ml propidium iodide. After a 10-min incubation at room temperature, the cells were examined under a fluorescence microscope (Axioskop 2, Zeiss, Germany). At least 500 cells were scored in each sample, and at least three independent measurements were performed to determine the percentage of apoptotic cells.
Results
Induction of prominent mitotic arrest by arsenite in CGL-2 cells When logarithmically growing CGL-2 cells were treated for 24 h with 0--10 mM of arsenite, a dose-dependent increase in the G 2 /M cell population was seen by flow cytometric analysis over the concentration range of 0--4 mM arsenite, followed by a decrease at the concentration above 5 mM ( Figure 1A ). Microscopic examination confirmed that the increased G 2 /M population was predominantly mitotic cells ( Figure 1A ). As 450% of the cells were arrested in the mitotic stage by treatment with 2--5 mM arsenite for 24 h, the mitotic arrest induced by arsenite in CGL-2 cells was clearly more prominent than that reported previously in other cell types (15--35% of cells arrested) (7,10,12--14,22) . Arsenite also induced cytotoxicity in CGL-2 cells in a dose-dependent manner as assessed by a colony-forming assay ( Figure 1B ). The level of mitotic arrest was inversely correlated with the relative survival rate in CGL-2 cells treated with 0--5 mM arsenite ( Figure 1C ), indicating that mitotic arrest was associated with arsenite-induced cell death. As mitotic cells are rounded-up, they can be separated from the attached interface cells by the shake-off technique. When the two cell populations were separated in this way from CGL-2 cells treated with 2 mM arsenite, the relative survival rates of the mitotic cells (filled square) and the remaining attached cells (empty square) were 4 and 96%, respectively, as compared with untreated cycling cells ( Figure 1B ). These results showed that arsenite induced mitosis-mediated cell death in CGL-2 cells.
Cell-cycle stage-independence of arsenite-induced mitotic arrest
To understand whether the arsenite-arrested mitotic cells originated from a specific cell-cycle stage, CGL-2 cells were synchronized at the G 1 stage by double thymidine block. The S-and G 2 -enriched populations were then obtained by incubating the thymidine-blocked G 1 cells in drug-free medium for 4 and 7 h, respectively ( Figure 2A ). As shown in Figure 2B --D, addition of 2 mM arsenite to the G 1 -, S-or G 2 -enriched culture did not significantly retard cell-cycle progression until the cells went into mitotic stage. Once the arsenite-treated G 1 , S or G 2 cells went into mitotic stage, they underwent cellcycle arrest, as indicated by the limited increase in the G 1 population at 10--25 h after release of thymidine block. These results showed that, on treatment with arsenite, all the cells, whether treated at G 1 , S or G 2 stage, progressed into, and arrested at, mitosis. However, it has been reported previously that, in other cell types, arsenite can induce cell-cycle arrest at the G 1 , S and G 2 stage, and also mitotic arrest, but to a lesser degree (7,10,12--14,22) . Our present results showed that CGL-2 cells with arsenite-induced injuries entered mitosis without proper cell-cycle arrest, suggesting that, interference with the G 2 checkpoint might be crucial in causing arseniteinduced mitotic arrest.
Accumulation of g-H2AX in arsenite-arrested mitotic cells
Several reports have demonstrated that arsenite can induce DNA damage (26--29) . To determine whether arsenite-arrested mitotic CGL-2 cells contained damaged DNA, the level of g-H2AX, a robust marker for DNA double-strand breaks (30) , was examined by both immunoblotting and immunofluorescence staining. In CGL-2 cells treated for 24 h with 2 mM arsenite, g-H2AX foci were clearly detectable in the interface nuclei ( Figure 3B ) and on the mitotic chromosomes ( Figure 3C ), whereas no g-H2AX signal was seen in untreated cells ( Figure 3A ). Immunoblot analysis showed that treatment of CGL-2 cells with 2 mM arsenite resulted in a timedependent increase in the levels of g-H2AX ( Figure 3D ). Accumulation of g-H2AX showed that DNA damage occurred in arsenite-treated CGL-2 cells. To determine whether arsenite-induced DNA damage was involved in the induction of mitotic arrest in CGL-2 cells, we compared the cellular responses to the insults induced by arsenite, X-irradiation, nocodazole and taxol. Flow cytometric and mitotic index Arsenite inhibits G 2 checkpoint activation analysis of the total cell population showed that, at 14 h after irradiation with a dose of 10 Gy of X-rays, 72.4% of CGL-2 cells had a doubled DNA content, but the mitotic index was only 4.9% ( Figure 4B ), indicating that X-irradiation predominantly caused G 2 arrest, whereas 24 h treatment with arsenite (2 and 4 mM), nocodazole (0.1 mM) or taxol (0.1 mM) induced substantial mitotic arrest (mitotic indices ranging from 54.3 to 73%, Figure 4C --F). Immunoblot analysis ( Figure 5 ) showed that the floating cells shaken off arsenite-, nocodazole-or taxol-treated cultures had high levels of cyclin B1, a marker of G 2 and mitotic cells. These cells also had high levels of both phosphorylated histone H3 (at serine 10), a mitotic marker, and Pds1, an anaphase inhibitor. Together, these results indicate that these cells were arrested at the mitotic stage. Conversely, X-irradiated cells showed high levels of cyclin B1, but no accumulation of phosphorylated histone H3 or Pds1, confirming G 2 arrest. In cells treated with nocodazole or taxol, spindle poisons but not DNA damaging agents, no g-H2AX signal was observed. However, in the arsenite-arrested mitotic cells, levels of g-H2AX were remarkably high, even higher than in 10 Gy X-irradiated cells, indicating that severe DNA damage had occurred in the arsenite-arrested mitotic CGL-2 cells.
Override of X-irradiation-induced G 2 arrest by arsenite in CGL-2 cells The G 2 DNA damage checkpoint is usually activated in response to DNA double-strand breaks and halts the cell cycle at the G 2 stage for DNA repair. The cell-cycle distribution of CGL-2 cells in response to X-irradiation was analyzed to understand whether arsenite inhibits the activation of the G 2 checkpoint and hence leads to the presence of damaged DNA in mitotic-arrested cells. When the mitotic index was examined at 30 min intervals starting immediately after irradiation with 5 Gy of X-rays, it fell from 6 to 0.7% within 2 h ( Figure 6A, empty circles) , indicating that the G 2 checkpoint was immediately activated upon X-irradiation of CGL-2 cells. However, this effect was abolished in the presence of 5 mM caffeine ( Figure 6A, filled circles) , an agent known to abrogate the G 2 checkpoint and override the G 2 arrest induced by DNA damage (31) , as indicated by the prevention of decrease in mitotic index. Thus, caffeine could override the immediate G 2 arrest induced by X-rays in CGL-2 cells. Similar results were obtained using 2 and 5 mM arsenite, showing that arsenite mimicked caffeine in abrogating the G 2 checkpoint and overriding the G 2 arrest induced by X-irradiation in CGL-2 cells (Figure 6A, triangles) . We also examined whether the G 2 checkpoint in CGL-2 cells could accumulate the cells at the G 2 stage when it was activated by X-irradiation. When G 2 accumulation was examined 14 h after irradiation of CGL-2 cells with X-rays at doses ranging from 0 to 20 Gy (Figure 6B content ( Figure 6B , filled triangle) and the increase in mitotic index ( Figure 6B , filled bar). However, when the cells were irradiated and incubated in the presence of 2 mM arsenite, the mitotic indices were significantly enhanced ( Figure 6C , slashed bars). These results indicate that the dose-dependent G 2 accumulation induced by X-irradiation was reduced and the G 2 -arrested cells were forced into mitosis by arsenite in the same manner as that of cells irradiated and incubated in the presence of caffeine. Since arsenite could also disrupt the function of mitotic spindles, these cells were therefore arrested at mitosis. These results indicated that arsenite could also mimic caffeine in attenuating the G 2 accumulation induced by X-irradiation. Together, these results confirmed that the components of the G 2 checkpoint pathway in CGL-2 cells responded normally to DNA damage-induced by X-irradiation and led to G 2 arrest, suggested that arsenite could disrupt the function of G 2 checkpoint and override X-ray-induced G 2 arrest in CGL-2 cells. Similar results were also obtained To further characterize the effects of arsenite on G 2 accumulation, we followed the cell-cycle progression of CGL-2 cells X-irradiated in the presence or absence of 2 mM arsenite and then incubated the cells for 22 h in the same medium. After Figure 7A and B, filled circles); similar results were seen in X-irradiated 2 mM arsenite-treated cells ( Figure 7A and B, filled triangles), thereby confirming that arsenite treatment could override the G 2 arrest induced by X-irradiation.
Suppression of X-irradiation-activated phosphorylation of ATM and Cdc25C by arsenite
In response to DNA double-strand breaks, the ATM-dependent DNA damage checkpoint is activated; this initiates subsequent cellular responses, including cell-cycle arrest and DNA repair. Phosphorylation of serine residues 1981 of ATM kinase and 216 of Cdc25C phosphatase is crucial for the activation of the DNA damage checkpoint signaling pathway and G 2 arrest (32, 33) . Therefore, we examined the effects of arsenite on these phosphorylation events after X-irradiation. As shown in Figure 8A , significant phosphorylation of the serine 1981 of ATM was seen at 1 h after 10 Gy X-irradiation, the level of phosphorylation then gradually decreased to 34 and 19% of the 1 h level at 7 and 14 h after X-irradiation, respectively ( Figure 8A ). When 2 mM arsenite was present during and after irradiation, the phosphorylation of serine 1981 of ATM at 1 h after 10 Gy X-irradiation was only 24% of that in cells irradiated with 10 Gy X-ray alone and decreased to 11 and 3% at 7 and 14 h, respectively ( Figure 8A ). Similar results were observed with 5 Gy X-irradiation. In addition, X-irradiation (4--16 Gy) induced significant serine 216 phosphorylation of Cdc25C, and 2 mM arsenite significantly suppressed this effect and increased the expression of the mitotic form of Cdc25C ( Figure 8B ). These results confirmed that arsenite could attenuate X-irradiation-induced activation of the G 2 checkpoint.
Higher susceptibility of triggering apoptosis in arsenite-arrested mitotic CGL-2 cells than nocodazole-and taxol-arrested mitotic cells Previous studies have shown that arsenite induces mitosismediated apoptosis (7, 10, 11, 13) . To examine the effect of the presence of DNA damage in arsenite-induced mitotic cells on the induction of apoptosis, we incubated arsenite-, nocodazoleand taxol-arrested mitotic CGL-2 cells for 24 h in drug-free medium and then examined them by Annexin V staining to assess apoptosis induction. When CGL-2 cells were treated for 24 h with arsenite, nocodazole or taxol at dose ranges that produced a similar frequency of mitotic cells, a higher frequency of apoptotic cells were seen in the arsenite-arrested mitotic cells than in those arrested by the other two spindle poisons (Table I) . For example, treatment of CGL-2 cells with 4 mM arsenite, 100 nM nocodazole or 50 nM taxol resulted in 66, 65 and 71% of the cells arrested at mitotic stage, respectively. After an additional 24 h-incubation in drug-free medium, 61% of the arsenite-arrested mitotic cells underwent apoptosis, which is significantly higher than the 22 and 41% observed in that of nocodazole-or taxol-arrested mitotic cells. Since arsenite-arrested mitotic CGL-2 cells showed marked accumulation of g-H2AX, a marker of DNA damage, whereas nocodazole-or taxol-arrested mitotic cells did not ( Figure 5 ), the presence of DNA damage in arsenite-arrested mitotic cells might play a role in enhancing the induction of apoptosis.
Discussion
Microtubule-targeted agents, such as paclitaxel and taxotere, are now often used in the treatment of a variety of human epithelial cancers. On binding to b-tubulin, these agents decrease microtubule dynamic instability, interfere with G 2 /M transition, induce mitotic arrest, and subsequently trigger the molecular signaling for the mitochondrial pathway of apoptosis (15, 16) . Arsenite, which is effective in the treatment of relapsed or refractory APL, has also been demonstrated to attenuate spindle dynamics and thereby induce mitotic arrest and mitosis-mediated apoptosis (11, 14) . However, the mechanism involved in how the cell-cycle perturbation induced by these anti-microtubule agents triggers apoptosis remains to be Arsenite inhibits G 2 checkpoint activation elucidated. In this study, we demonstrated that arsenite induces a more prominent mitotic arrest in CGL-2 cells than in other cell lines studied (7,10,12--14,22,34) . In contrast to previous studies, arsenite did not alter the progression of each cell-cycle stage in CGL-2 cells. Furthermore, our results showed that arsenite could mimic caffeine in overriding X-irradiationinduced G 2 arrest. Together, these results indicated that arsenite might disrupt the function of DNA damage checkpoint, and thereby allowing CGL-2 cells with damaged DNA to continue their cell-cycle progression. As arsenite also interferes with the function of mitotic spindles (7, 10, 14) , the arsenite-treated CGL-2 cells are finally arrested in mitotic stage with the presence of DNA damage. As arsenite treatment causes DNA damage, inhibits G 2 checkpoint activation and interferes with the function of spindle checkpoint (35) , the arsenite-arrested mitotic CGL-2 cells consequently manifest higher susceptibility to induction of apoptosis than those treated with nocodazole or taxol. In normal cells, DNA damage activates DNA damage checkpoint pathways that inhibit the progression of cells through the G 1 and G 2 phases and induces a transient delay in progression through S phase (36, 37) . Cell-cycle arrest before mitosis would allow cells time to repair DNA damage and, thereby preventing the transmission of genetic errors to daughter cells. Previous reports have demonstrated that arsenite could induce a significant cytostatic effect on human diploid fibroblasts, which contain wild-type p53 and normal cell-cycle checkpoint functions (12, 38) . On the other hand, arsenite induced G 2 and mitotic arrest instead of G 1 arrest in SV-40 transformed human diploid fibroblasts in which the p53 and Rb are inactivated by sequestration of SV-40 T antigens (12) . Moreover, arsenite also induced a significant increase of cells at G 1 stage in a myeloma cell line with wild-type p53 whereas arsenite induced G 2 and mitotic arrest in myeloma cell lines with mutant p53 (34, 39) . These results indicated that arsenite might induce G 1 arrest in a p53-dependent manner. We have demonstrated previously that arsenite could induce DNA damages and result in p53 accumulation and activation in normal diploid fibroblasts (38) . Loss of p53 function might prevent the induction of G 1 arrest and lead to G 2 and mitotic arrest in arsenite-treated cells. Most cell lines that lack functional p53 protein are often arrested in the G 2 stage due to These results implied either that the arsenite-induced DNA damage could not properly activate the G 2 DNA damage checkpoint or that arsenite might inactivate or abrogate the G 2 DNA damage checkpoint in CGL-2 cells. In response to DNA double-strand breaks, the ATMdependent DNA damage checkpoint is activated and initiates the subsequent cellular responses, including cell-cycle arrest and DNA repair (30) . Ionizing irradiation induces rapid intermolecular autophosphorylation at serine 1981 of ATM and thus enhances the kinase activity of ATM (41) . The enhanced kinase activity activates checkpoint kinase (Chk)-2 by phosphorylation at threonine 68. The activated Chk-2 subsequently phosphorylates Cdc25C at serine 216 and blocks its function (32, 33) . This inhibitory phosphorylation of serine 216 of Cdc25C increases its binding to 14-3-3, reduces its catalytic activity, and causes its sequestration in the cytoplasm (32, 33) . Without the phosphatase activity of Cdc25C, the mitotic cyclin-dependent kinase can no longer be activated; therefore, cells are arrested at the G 2 stage. Based on our present results showing that arsenite treatment reduces phosphorylation of both the serine 1981 of ATM and the serine 216 of Cdc25C, we conclude that arsenite can attenuate or inactivate the G 2 DNA-damage checkpoint. Arsenite-treated CGL-2 cells with damaged DNA therefore are not inhibited from entering mitosis, resulting in a prominent mitotic arrest. Our previous report has demonstrated that arsenite could significantly increase the histone H1 kinase activity of cyclin-dependent kinase 1 and also induce a significant mitotic arrest (35%) in HeLa S3 cells (14) . In this study, similar effects of arsenite on G 2 checkpoint abrogation were also observed in HeLa S3 cells. These results indicate that attenuation of G 2 DNA damage checkpoint by arsenite might result in the prominent mitotic arrest in arsenite-treated CGL-2 and HeLa S3 cells and suggest that arsenite could inhibit the G 2 checkpoint in other solid cancer cells. Further investigation of how arsenite attenuates the G 2 DNA damage checkpoint is of great importance in elucidation of the action mechanism and the therapeutic implication of arsenite. Pharmacological abrogation of the DNA damage checkpoint is frequently used in combination with DNA damaging agents in cancer chemotherapy. The targets are mainly kinases involved in the signaling pathway of DNA damage checkpoint, such as ATM, ATM-related, Chk-1 and Chk-2. The most efficacious checkpoint inhibitors found so far are caffeine, which inhibits DNA damage-proximal targets, such as ATM (31), UCN-01, which inhibits multiple targets, such as Chk-1 and Wee1 (42) , and debromohymenialdisine, which inhibits Chk-1 and Chk-2 (43). These kinase inhibitors simply interfere with kinase activity without inducing DNA damage and mitotic arrest. A combination of checkpoint kinase inhibitors and DNA damaging agents is therefore used to increase the killing efficiency. On the other hand, over-expression of type I protein phosphatase releases the G 2 checkpoint activated by DNA damage, induces aberrant mitoses, and sensitizes cells to DNA damage (44) . In the present study, we demonstrated that the X-irradiation-induced G 2 DNA damage checkpoint could be suppressed and DNA damage-induced G 2 arrest overridden by arsenite in CGL-2 cells. We also demonstrated that arsenite deregulated the components involved in G 2 DNA damage checkpoint pathways. Therefore, we suspect that abrogation of the G 2 DNA damage checkpoint by arsenite might sensitize cancer cells to ionizing radiation. It has been reported that arsenic trioxide can sensitize human cervical cancer cells to ionizing radiation both in vitro and in vivo, since co-treatment synergistically enhanced radiation-induced G 2 /M accumulation and apoptosis (6) .
Arsenite-arrested mitotic CGL-2 cells were also more susceptible to apoptosis than those arrested by nocodazole or taxol, indicating that arsenite may act in a different mechanism to induce mitotic arrest. When mammalian cells with DNA replication defects or DNA damage (e.g. if the G 2 /M checkpoint is defective or is overruled) enter mitosis, their centrosomes break up during mitosis, multipolar spindles appear, and aneuploid cells are produced (17) . Centrosome and spindle abnormalities may therefore be a general response of mammalian cells when DNA defects persist in mitosis. There is evidence for a strong link between the DNA damage-induced checkpoint signaling pathway and the induction of abnormal centrosomes and malfunctioned mitotic spindles, leading to the activation of spindle checkpoint and mitotic arrest (45, 46) . In addition to attenuating the spindle checkpoint and thus inducing the abnormal onset of anaphase (35) , arsenite also causes DNA damage (26--29) . Thus, the combined effects of arsenite in inducing DNA damage, inhibiting the G 2 checkpoint, and attenuating the spindle checkpoint may make arsenite-arrested mitotic CGL-2 cells more susceptible to induction of apoptosis than those treated with nocodazole or taxol. The CGL-2 cells were incubated for 24 h with or without arsenite, nocodazole or taxol at the indicated concentrations and then the mitotic index was measured. In a parallel series of experiments, the floating mitotic cells were gently shaken off and re-incubated in drug-free medium for 24 h. The percentage of apoptotic cells was then analyzed using an Annexin V--FITC apoptosis detection kit and a fluorescence microscope. The data presented are the mean AE SD of three independent experiments.
Arsenite inhibits G 2 checkpoint activation
Arsenic has pleiotropic effects on many biological systems and induces complex toxicopathological injuries (47--50) including the generation of reactive oxygen species, induction of DNA damage, disruption of mitochondrial function, modification of gene and/or protein expression and intracellular signal transduction pathways, alteration of cell-cycle progression, and induction of cytogenetic aberrations and cellular transformation. These deleterious effects have been suggested to be involved in arsenite-induced apoptosis. These multiple actions of arsenite highlight the need for additional mechanistic studies to determine which actions mediate the diverse biological effects of this agent. Gaining a better insight into the mechanisms of action of arsenic compounds might allow us to increase their therapeutic effects while reducing toxic sideeffects and to develop better regimens for cancer therapy. Although we do not yet fully understand how arsenite abrogates the DNA damage checkpoint, our results demonstrate that alteration of the DNA damage checkpoint plays a significant role in the induction of mitotic abnormalities and apoptosis by arsenite, which might be a great help in terms of cancer therapy, especially in tumors with p53 mutations or which have developed chemoresistance. This information will be critical in realizing the potential of the synergy between arsenite and other chemotherapeutic agents, thus providing enhanced benefit in cancer therapy.
